Tridin

Quick links to important sections

Tridin

Method of action: Vitamins

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tridin

Property Description
Active Ingredient Calcium, Sodium Monofluorophosphate
Form Dentifrice (Paste/Gel), Oral Tablet
Pharmacological Class Anti-caries Agent, Fluoride Compound
Common Use Prevention of Dental Cavities (Caries)
Origin Inorganic, Synthetic (Sodium Monofluorophosphate)

Tridin: Definition and High-Level Pharmacological Class

Tridin refers to a combination product classified as a specialized Dental Agent and Anti-caries Agent, formulated to support the mineralized structure of tooth enamel. The product’s core identity is defined by two principal active ingredients: a source of Calcium and the inorganic fluoride source, Sodium Monofluorophosphate (SMFP).

This formulation is broadly recognized as an Anticaries Drug Product for Over-the-Counter Human Use. Sodium Monofluorophosphate (SMFP) is an inorganic salt clinically recognized for its essential role in preventing dental decay. Tridin is designed for topical application (Dental/Oral) in high-viscosity dentifrice forms, ensuring the active components are concentrated directly at the site of action.

Composition, Origin, and the Role of Key Components

The composition integrates the synthetic anticaries agent Sodium Monofluorophosphate alongside a naturally sourced mineral, Calcium. This pairing is deliberate: Calcium provides the essential mineral building blocks for the tooth structure, while Sodium Monofluorophosphate acts as the catalyst by releasing the necessary fluoride ion.

The released fluoride ion is critical because it integrates into the enamel, chemically converting the naturally occurring, less resistant mineral structure (hydroxyapatite) into the more stable and acid-resistant fluorapatite. This mechanism ensures that both the raw material and the chemical environment required for robust structural enhancement are delivered concurrently.

General Purpose: Supporting Enamel Strength and Integrity

The high-level general purpose of Tridin is to achieve durable enamel strengthening and effective remineralization, which directly contributes to the prevention of dental cavities (caries). The product works by supporting a crucial chemical change in the outer layer of the tooth structure. This results in a tooth surface that is physically harder and significantly more resilient against the daily acid attacks from oral bacteria, supporting the tooth’s continuous defense and structural maintenance.

Regulatory References

  1. NIH MedlinePlus, Fluoride: Uses

What side effects are possible with Tridin?

Possible Side Effects and Safety Information

The official safety documentation for Tridin (Sodium Monofluorophosphate dentifrice) is structured around minimizing risks associated with systemic overexposure rather than classifying adverse effects from intended topical use. For the recommended application, regulatory documents do not list side effects using common frequency categories (e.g., Common, Uncommon, Rare).


Adverse Reactions and System-Organ Class Focus

The primary safety concerns documented relate to excessive or inappropriate ingestion of the fluoride component, categorized under two main system-organ classes:

  • Dental/Oral System: The most recognized long-term risk associated with chronic, excessive systemic fluoride intake during tooth development is Dental Fluorosis. This condition is characterized by changes in the appearance, such as discoloration or staining, of the tooth enamel.
  • Gastrointestinal System: Acute, excessive accidental ingestion of the product may result in gastrointestinal disturbances or stomach upset. Official labeling requires a statement that if a quantity greater than is used for brushing is accidentally swallowed, immediate medical assistance should be sought.

Population-Specific Safety Constraints

The product labeling includes specific constraints for the Pediatric Population. To mitigate the risk of accidental over-ingestion and the potential for dental fluorosis during the critical years of tooth development, the product must be kept out of reach of children under six years of age. This safety constraint defines a clear boundary for safe exposure.

Overdose and Emergency Response

Overdose with Tridin, a fluoride compound, is primarily characterized by the officially documented symptoms of acute fluoride toxicity. Initial manifestations frequently involve the gastrointestinal system, including nausea, vomiting, stomach cramps, and diarrhea. Systemic clinical signs such as weakness, tremors, and shallow breathing may also occur.

Acute ingestion of an amount exceeding what is typically used for brushing requires immediate, mandated action. Individuals, or those assisting them, must contact emergency services or a Poison Control Center right away. This urgency is due to the potential for severe, life-threatening outcomes, including critical metabolic disturbances like hypocalcemia, and serious cardiovascular effects such as an irregular heartbeat or cardiac arrest.

Management procedures officially described in regulatory sources include providing symptomatic and supportive treatment. These measures may involve the administration of oral calcium-containing substances, such as milk, as an initial step. Monitoring in a clinical setting typically requires an Electrocardiogram (ECG) and relevant blood and urine tests. A specific warning exists for children under six, who require immediate medical help after accidental overdose, and who face a risk of permanent tooth discoloration (dental fluorosis) from prolonged excessive intake during tooth development.

Therapeutic Uses of Tridin

What Tridin Treats: Main Uses and Benefits

Tridin is commonly used to manage conditions characterized by periods of heightened physiological stress on the tooth structure, focusing on dental caries (cavities) and enamel decalcification. This therapeutic category is relevant when supportive symptom management is appropriate for the structural integrity of the tooth, and may assist with managing the progression of early decay.

The medication is used in situations involving certain distressing symptoms related to physical discomfort, specifically dental hypersensitivity, which is often characterized by sharp discomfort triggered by hot, cold, or sweet stimuli. Indications include: caries prevention, management of initial carious lesions, and symptomatic support for hypersensitivity.

This application is relevant in clinical settings marked by a high risk of recurrent decay, where it is applied in addressing initial lesions to contribute to the maintenance of the overall tooth structure.

“The primary goal of this therapeutic approach is to support the tooth’s structural defense and contribute to easing discomfort during symptomatic periods.”

Quick Fact: Symptomatic Support for Dental Hypersensitivity

Tridin supports the patient during difficult episodes by easing distress, which generally contributes to easing discomfort during symptomatic periods and may assist with supporting functional stability for individuals at elevated caries risk.

Regulatory References

  1. NIH National Institute of Dental and Craniofacial Research

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Tridin

The official eligibility rules for Tridin, an over-the-counter (OTC) anticaries agent containing Sodium Monofluorophosphate and Calcium, are primarily established by government regulatory monographs to mitigate the risk of systemic fluoride overexposure.

Populations for whom use is contraindicated:

  • Individuals with a known hypersensitivity or allergy to Sodium Monofluorophosphate or any other component of the formulation.
  • Patients with severe kidney disorders, due to the risk of systemic fluoride accumulation, which may be explicitly contraindicated for the active ingredient class.

Age-related eligibility rules:

Age Group Eligibility Status (Regulatory Basis)
Children under 2 years Not Recommended/Conditional Use. Requires consultation with a dentist or doctor, as OTC use is not established.
Children 2 to under 6 years Restricted Use. Eligible but requires adult supervision to minimize accidental swallowing.
Children 6 years and older Eligible. Use is generally permitted, though supervision is often advised until age 12 to ensure proper technique.

Condition-specific and physiological limitations:

  • Severe Renal Impairment: Use of the fluoride component is contraindicated in severe kidney disorders to prevent systemic accumulation.
  • Pregnancy and Lactation: While generally considered safe for topical use, official labeling recommends consulting a doctor for advice tailored to the specific health condition.

These constraints define the regulatory profile, ensuring the medicine is used only by approved populations and under the label's specified conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Tridin (Sodium Monofluorophosphate / Calcium) defines interaction patterns based on the chemical properties of its active components, rather than systemic metabolic pathways.


Pharmacodynamic and Local Availability Interactions

Interacting Substance Category Official Interaction Description Resulting Regulatory Constraint
Mineral Cation-Containing Products Substances containing Calcium, Aluminum, or Magnesium salts bind the fluoride component through chelation. Mandatory administration time separation is required to preserve the local availability and efficacy of the product.
Other Fluoride Sources Co-administration with high-concentration fluoride gels, rinses, or supplements leads to an additive increase in total fluoride exposure. Use must be considered within the context of total fluoride intake from all sources to mitigate the documented risk of fluorosis.

Administration Constraints

Regulatory documentation states that products containing high levels of Calcium or other metal cations, such as certain antacids or dietary supplements, must be consumed or administered at a time separate from Tridin. This precaution is necessary to prevent the formation of insoluble fluoride complexes, which is officially described as reducing the amount of active fluoride available for anti-caries action. There are no documented pharmacokinetic interactions with systemic drugs involving CYP enzymes or drug transporters for this topically used product.

Mechanism of Action

How Tridin Works: Pharmacodynamic Mechanism

Tridin exerts its effects through three primary mechanistic domains. The core action involves functioning as an antagonist at the Histamine H1 receptors . This molecular interaction prevents the endogenous agonist histamine from binding and initiating signal transduction. This action contributes to the modulation of localized signaling at capillary and nerve endings, resulting in reduced vascular permeability and modified afferent nerve activity, which affects tissue fluid dynamics.

A secondary, complementary effect involves the drug's activity as an agonist at alpha1 adrenergic receptors on vascular smooth muscle. Activation of these receptors causes smooth muscle contraction, leading to vasoconstriction. This affects vascular tone and results in localized reduction of blood flow and pressure, influencing the volume of fluid movement into surrounding tissues.

Finally, Tridin modulates activity within specific pathways in the Central Nervous System (CNS), including the brainstem reflex centers. This influence on neuronal excitability alters the firing pattern of specific involuntary reflexes, contributing to the drug's observable systemic effects.

Dosage and Administration Information

How Tridin is Used: Official Administration Guidelines

Tridin is used in a dual administration protocol reflecting its two available forms: a topical/dental route for the dentifrice and an oral route for the tablet. The dentifrice is applied at least twice daily as part of a continuous maintenance schedule for caries prevention, typically in the morning and evening.

Dosing and Administration

The dosage for the oral tablet is not fixed but is strictly individualized based on the patient's age and the measured fluoride concentration in the local drinking water supply. This dose proportionality ensures adherence to established safety standards. The tablet is generally taken once daily, often at bedtime, and may be instructed to be chewed or dissolved in the mouth before swallowing.

For the topical dentifrice, the procedural constraint requires the product to be expelled (spit out) after brushing, as it is not intended for ingestion. Children under six years of age must use only a pea-sized amount, necessitating adult supervision during application to minimize the overall quantity swallowed. Furthermore, to maximize contact time, patients are instructed to avoid eating or drinking for 30 minutes after use. If an oral tablet dose is missed, the standard protocol is to skip the missed dose and resume the schedule the following day.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tridin


Evidence for Use in Preventing Dental Cavities (Caries)

Research for the primary anti-caries agent in Tridin (Sodium Monofluorophosphate, or SMFP) comes from numerous long-term randomized controlled trials (RCTs). These multi-year studies primarily involved populations of children and adolescents, with research examining the observed rate at which new dental cavities formed over time. Studies monitored the number of new decayed, missing, or filled tooth surfaces (DMFS/DFS) across observation periods that typically lasted two to three years.

These long-term studies reported similar patterns of results across multiple settings. Findings describe patterns observed in the studies, noting that the agent was observed to be associated with a lower measured rate of new lesion development compared to a placebo. Additionally, short-term laboratory and clinical research has examined the physical outcome, reporting how the agent interacts with the tooth surface to measure changes in mineral content and its acid stability.

Evidence for Use in Symptomatic Support for Hypersensitivity

Research for the application of Tridin in addressing dental hypersensitivity involves studies used in research exploring how patient-reported outcomes describing perceived discomfort change over short periods. This includes short-term randomized trials applied in studies examining patient-reported experiences from adult populations experiencing sharp discomfort triggered by hot, cold, or sweet stimuli. Research was monitored over defined time intervals, often lasting from a single application up to eight weeks.

These clinical studies were conducted during periods of increased symptom activity and explored short-term symptom changes. Trials reported how symptoms evolved in the observed populations, describing patterns related to patient-reported outcomes for perceived discomfort upon exposure to typical triggers. However, the evidence for this use is often derived from trials in which the fluoride agent was combined with other recognized desensitizing ingredients. This research provides context but does not determine whether an individual will respond similarly, leaving an evidence gap regarding the specific contribution of the fluoride component alone.

Key Studies & References

  1. An Update on the Review of Desensitizing Agents (PubMed Central)
  2. Fluoride Topical: Uses and Health Information (MedlinePlus)
  3. Fluoride in the Prevention of Dental Caries (NIH National Institute of Dental and Craniofacial Research)

Frequently Asked Questions (FAQ)

Common questions about Tridin (FAQ)


Q: How quickly does Tridin start working?

Absorption of the active fluoride ingredient from ingested oral tablets or solutions generally leads to maximum concentrations in the blood within 20 to 60 minutes. This range describes the time it takes for the ingredient to be fully available in the body.

Q: How long do the effects of Tridin last?

The active fluoride component typically has a terminal plasma elimination half-life ranging from 3 to 10 hours. This measure relates to the duration of its presence in the body before the substance is eliminated.

Q: Is it common to feel dizzy when starting Tridin?

Official product information states that dizziness is a frequent adverse reaction associated with the H1 antagonist component of the medicine. Patients are advised to be aware of this possibility, as noted in the product information.

Q: Are there any foods or drinks that should be avoided when using Tridin?

Regulatory guidance recommends avoiding mixing the oral tablet with milk or other foods and drinks that contain a significant amount of calcium. This is because the calcium can bind to the fluoride, potentially reducing the amount of the active ingredient that the body absorbs.

Q: Does Tridin interact with alcohol?

Regulatory warnings advise caution regarding the concurrent use of this medicine with alcohol. This combination may increase the central nervous system (CNS) depressant effects, such as drowsiness, caused by Tridin.

Q: Is it okay for older people (seniors) to use Tridin?

The medication's regulatory profile notes that older patients may be more susceptible to certain adverse effects, including dizziness, sedation, or a drop in blood pressure. The regulatory documents note that precautions are typically included for patients with pre-existing kidney issues.

Q: Is Tridin a controlled substance?

Official regulatory documents classify the medicine's active components. The H1 antagonist component is generally not listed as a controlled substance.

Q: Is Tridin approved in Europe (like by the EMA)?

The active ingredient, Sodium Monofluorophosphate, is regulated and listed by major global health authorities, including those in Europe. It is approved for use in various dental products under established guidelines.

Q: Can Tridin affect sleep patterns?

The H1 antagonist component frequently lists sleepiness, somnolence (drowsiness), and sedation as common adverse reactions. These effects indicate that the medicine can alter normal sleep/wake cycles.

Q: Does Tridin have a potential for dependence or addiction?

Based on regulatory classifications for its active components, the product is not typically associated with dependence or addiction. Official warnings do not list this as a major risk factor.

Q: Is it normal to feel tired after taking Tridin?

Official safety information indicates that fatigue or sleepiness is frequently reported. These are among the most frequent adverse reactions for H1 antagonists with CNS activity.

Q: Can people with liver issues take Tridin?

Regulatory documents specify whether the H1 antagonist requires a dose adjustment or carries specific precautions for patients with hepatic (liver) impairment. The official label contains specific guidance on the use of the product for patients with hepatic impairment.

Q: Does Tridin need to be taken with food?

Instructions for taking the oral tablet can vary based on the specific product label. Official administration information describes whether it is recommended to be taken with or without food for optimal absorption.

Q: Does Tridin cause weight changes (gain or loss)?

Some H1 antagonists have documentation listing weight increase as a potential, though often infrequent, adverse reaction. This is noted in official safety information.

Q: Are there any special warnings for people with heart conditions who use Tridin?

The product's dual mechanism of action, which includes an alpha1 agonist component, necessitates special precautions. Regulatory warnings typically include precautions for patients with pre-existing cardiovascular conditions, such as hypertension or heart failure.

Q: Is 'Tridin' the brand name or the name of the active chemical?

Tridin is the proprietary name (the brand name) for the product. The actual active chemicals contained in the medication are Sodium Monofluorophosphate and Calcium.

Q: Can Tridin affect my ability to drive or operate machinery?

Official warnings state that precautions must be taken regarding driving or operating heavy machinery. These warnings are included because side effects like drowsiness or dizziness may occur, as noted in the product information.

Q: Is it possible for Tridin to stop working after a while?

Regulatory documentation sometimes addresses the potential for a reduction in the effect of the active ingredients over long periods. This potential for a loss of efficacy is known in pharmacology as tolerance.

Q: Does the body build up a tolerance to Tridin?

Regulatory information may address whether the active components are known to cause pharmacological tolerance. This is defined as a reduction in responsiveness during chronic use.

Q: Do Tridin side effects usually go away after a few days?

Regulatory documents generally describe adverse effects but rarely provide definitive timelines for the resolution of minor, non-serious side effects like stomach upset. Information may offer general guidance that common effects are often transient.

Q: Can Tridin be taken with over-the-counter cold medicines?

Labels typically include precautions regarding concurrent use of Tridin with other over-the-counter cold medicines. This is because many contain similar ingredients, which can lead to additive side effects like increased drowsiness or enhanced cardiovascular effects.

Q: What are the general expectations for someone starting Tridin?

Official labeling includes a 'Patient Counseling Information' section. This is designed to prepare the patient by outlining the medication's expected dental benefits while advising of potential common side effects like drowsiness or dizziness.

Q: What does the patient leaflet for Tridin say about long-term use?

The regulatory basis for the active fluoride component indicates that official information describes the product as being generally suitable for daily, long-term oral use when administered as directed and within established safety limits.

Q: Why is Tridin prescribed to so many people?

The medicine is indicated for the prevention of dental caries (cavities). Since dental decay is a highly prevalent health condition globally, the product is widely recommended and used to address this public health issue.

Q: How long is Tridin typically prescribed for?

The product is designed to be part of a continuous maintenance schedule to prevent dental decay. Therefore, regulatory guidelines reflect a model of ongoing use rather than short-term treatment.

Q: What kind of research studies have been done on Tridin's anti-inflammatory mechanism?

Regulatory documents may contain information on pharmacodynamic studies that address the H1 antagonist and alpha1 agonist mechanisms. This research may be mentioned separately from the primary clinical trials focused on its dental application.

How should Tridin be stored and disposed of?

How to Store and Dispose of Tridin (Calcium and Sodium Monofluorophosphate)

Storage Requirements

Storage Condition Requirement
Temperature Store at room temperature and in a cool place
Protection Keep in a dry area to protect from moisture
Child Safety Mandatory to store out of reach of children under 6 years of age
Handling Keep the container tightly closed and the tube capped when not in use

The requirement for a dry, cool environment is essential for stability and maintaining the product's quality over its designated shelf-life. Keeping the container sealed minimizes the degradation of the active ingredient.

Disposal Instructions

Unused or expired Tridin must be disposed of in accordance with local, regional, and national regulations. To discard in household trash, the product should be removed from its container, mixed with an undesirable substance (such as cat litter or dirt), and sealed in a container or bag. Environmental release, such as flushing into surface water or sewer systems, must be avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tridin found in:

A-Z Index: